Truly Translational has solid experience in working with both small and large molecules. Their key therapeutic areas are inflammation, respiratory diseases, autoimmune diseases and oncology. As a member of the Medicon Valley Inhalation Consortium the company possesses access to unique competence and capabilities within inhalation, where Truly Translation offers pre-clinical in vivo inhalation pharmacology services.
Truly Translational Sweden
Truly Translational helps their customers to bring drug projects from preclinical in vitro studies and animal models, via common biomarker strategies, into concept testing in patients.
